Fla. Pharmacy Says Obesity Drug Suit Is Preempted By FDCA
A Florida pharmacy accused by Novo Nordisk of selling a compounded version of a popular weight loss drug said the pharmaceutical company lacks standing to sue in federal court because it...To view the full article, register now.
Already a subscriber? Click here to view full article